Smart implant - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,853,523 | 2,678,228 | 1,515,494 | 656,552 | 378,112 | 405,499 | 416,505 | 3,008 |
| Profit before tax | 978,674 | 642,299 | 20,360 | -153,540 | -36,065 | -438,855 | -2,509,389 | 191,555 |
| Net profit | 822,224 | 539,398 | 2,797 | -153,540 | -36,065 | -442,105 | -2,511,099 | 190,247 |
| Equity | 4,174,563 | 4,713,961 | 4,716,758 | 4,563,218 | 4,527,154 | 4,295,009 | 1,783,910 | 1,974,157 |
| Liabilities | 364,044 | 621,059 | 534,858 | 511,545 | 451,354 | 508,281 | 386,703 | 103,990 |
| Non-current assets | 2,094,779 | 2,944,550 | 1,239,841 | 1,307,020 | 1,525,606 | 1,644,000 | 1,870,410 | 1,906,261 |
| Current assets | 2,442,180 | 2,390,470 | 4,008,837 | 3,764,656 | 3,451,265 | 3,158,126 | 300,174 | 171,886 |
| Total assets | 4,536,959 | 5,335,020 | 5,248,678 | 5,071,676 | 4,976,871 | 4,802,126 | 2,170,584 | 2,078,147 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | - | 82,078 | 5,007 |
| Social insurance contributions | - | - | - | - | - | 45,118 | 39,434 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | +8.8% | -6.1% | -43.4% | -56.7% | -42.4% | +7.2% | +2.7% | -99.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 18.1% | 10.1% | 0.1% | -3.0% | -0.7% | -9.2% | -115.7% | 9.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 19.7% | 11.4% | 0.1% | -3.4% | -0.8% | -10.3% | -140.8% | 9.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 28.8% | 20.1% | 0.2% | -23.4% | -9.5% | -109.0% | -602.9% | 6324.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 34.3% | 24.0% | 1.3% | -23.4% | -9.5% | -108.2% | -602.5% | 6368.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 265,444 | 189,051 | 89,147 | 49,865 | 42,012 | 47,706 | 57,449 | 3,008 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Smart implant - Social security debts
The company had no debts to Sodra
Smart implant - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-12-18 | 2024-12-19 | 5.72 |
| 2024-12-12 | 2024-12-17 | 1315.64 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Smart implant, UAB (code 300588617) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated €3.0K in revenue and reported net profit of €190.2K, after losses of €442.1K in 2023 and €2.51M in 2024. Revenue was €405.5K in 2023 and €416.5K in 2024, before falling sharply in 2025, so the latest profitability metrics should be read in the context of a very small turnover base. The 2025 balance sheet shows total assets of €2.08M, equity of €1.97M and liabilities of €104.0K. Equity represented 95.0% of assets, and debt remained low with a debt-to-equity ratio of 0.05. Return on equity was 9.6% and return on assets 9.2% in 2025. Long-term assets amounted to €1.91M and short-term assets to €171.9K. Revenue per employee was €3.0K, while profit per employee reached €190.2K, reflecting the very limited scale of operating income in the latest year.